1. Home
  2. AIIO vs PRTA Comparison

AIIO vs PRTA Comparison

Compare AIIO & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Robo.ai Inc. Class B Ordinary Shares

AIIO

Robo.ai Inc. Class B Ordinary Shares

HOLD

Current Price

$3.20

Market Cap

469.1M

Sector

Industrials

ML Signal

HOLD

Logo Prothena Corporation plc

PRTA

Prothena Corporation plc

HOLD

Current Price

$8.55

Market Cap

449.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIIO
PRTA
Founded
N/A
2012
Country
United Arab Emirates
Ireland
Employees
29
N/A
Industry
Auto Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
469.1M
449.7M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
AIIO
PRTA
Price
$3.20
$8.55
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
$19.00
AVG Volume (30 Days)
886.9K
538.7K
Earning Date
05-27-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.26
Revenue
N/A
$814,000.00
Revenue This Year
N/A
$1,111.38
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$33.69
Revenue Growth
N/A
N/A
52 Week Low
$0.07
$7.50
52 Week High
$9.20
$11.80

Technical Indicators

Market Signals
Indicator
AIIO
PRTA
Relative Strength Index (RSI) 44.95 N/A
Support Level $2.60 N/A
Resistance Level $4.96 N/A
Average True Range (ATR) 0.25 0.00
MACD -0.02 0.00
Stochastic Oscillator 51.08 0.00

Price Performance

Historical Comparison
AIIO
PRTA

About AIIO Robo.ai Inc. Class B Ordinary Shares

Robo.ai Inc is a decentralized, AI-powered intelligent mobility platform that integrates smart vehicles, robotics, and blockchain technologies. The company is developing an AI-NAS ecosystem focused on delivering a passenger-centric platform by combining hardware and software, leveraging onboard computing, and offering an open cloud environment. Its product portfolio includes MUSE, a full-sized autonomous electric SPV; GHIATH, a purpose-built vehicle for public services and law enforcement developed in collaboration with Dubai Police; and Astra, an autonomous logistics vehicle. It also offers other vehicle models such as NWONE (SUV), Rabdan One (SUV), and Rabdan Seven (MPV) in the UAE through the SKD model. The company operates across the USA, UAE, and Mainland China.

About PRTA Prothena Corporation plc

Prothena Corp PLC is a late-stage clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. Prothena is developing and applying its proprietary CYTOPE technology to target a broad spectrum of intracellular disease pathways in the brain and periphery. The company's pipeline includes both wholly-owned and partnered programs like Prasinezumab, Coramitug (PRX004), BMS-986446 (PRX005), PRX019, TDP-43 CYTOPE, and PRX012-TfR, being developed for the potential treatment of Parkinson's disease, ATTR amyloidosis with cardiomyopathy, Alzheimer's disease, Amyotrophic lateral sclerosis (ALS), and other neurodegenerative diseases.

Share on Social Networks: